Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> from Five Latin American Countries

• Main Authors: Juan Carlos García-Betancur (Author), Elsa De La Cadena (Author), María F. Mojica (Author), Cristhian Hernández-Gómez (Author), Adriana Correa (Author), Marcela A. Radice (Author), Paulo Castañeda-Méndez (Author), Diego A. Jaime-Villalon (Author), Ana C. Gales (Author), José M. Munita (Author), María Virginia Villegas (Author)
• Formato: Livro
• Publicado em: MDPI AG, 2022-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Ceftolozane/tazobactam (C/T) is a combination of an antipseudomonal oxyiminoaminothiazolyl cephalosporin with potent in vitro activity against <i>Pseudomonas aeruginosa</i> and tazobactam, a known β-lactamase inhibitor. The aim of this study was to evaluate the activity of C/...